CompoAtlas

Microcirculation

Microcirculation, licence 80059914: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
EM Canada
Licence holder
Nutragenius Inc.
NPN or DIN-HM
80059914
Status
Inactive licence
Licence date
14 April 2015
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
3,3',4',5,7-pentahydroxyflavone

Source : Fruit

150.0 mgNot calculated
Vitamine C

Source : Acide ascorbique

80.0 mg320,000 µg
Vaccinium angustifolium

Source : Fruit

Extraction ratio : 40:1

Dry plant equivalent : 1200 mg

30.0 mgNot calculated
Haematococcus pluvialis

Source : En entier

Potency : 1.5 % Astaxanthin

100.0 mgNot calculated
L-théanine

Source : Feuille

60.0 mgNot calculated
2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl

Source : bactéries, levures

15.0 mgNot calculated
Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque

Source : Monohydrochlorure de L-arginine

30.0 mgNot calculated
Ginkgo biloba L.

Source : Feuille

Extraction ratio : 50:1

Dry plant equivalent : 1.5 g

Potency : 6.0 % Terpene lactones

30.0 mgNot calculated
Ginkgo biloba L.

Source : Feuille

Potency : 24.0 % Flavone glycosides

Not specifiedNot calculated

Non-medicinal ingredients

Hypromellose, chlorophylle

PopulationAgeQuantity per servingFrequency
AdultesNot specified2.0 Capsule2.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps to maintain and/or support cardiovascular health. Helps to support peripheral circulation. Helps to enhance memory in adults. Source of antioxidants for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80059914

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line